| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
5.09 |
% |
10.6019/CHEMBL4513141 |
| Bos taurus |
Cytochrome P450 11A1 |
IC50 |
29000.0 |
nM |
10.1021/jm00090a010 |
| Bos taurus |
Cytochrome P450 11A1 |
IC50 |
30000.0 |
nM |
10.1021/jm00392a004 |
| Bos taurus |
Cytochrome P450 11A1 |
IC50 |
30000.0 |
nM |
10.1021/jm00400a014 |
| Bos taurus |
Cytochrome P450 11A1 |
Inhibition |
14.0 |
% |
10.1021/jm00355a011 |
| Bos taurus |
Cytochrome P450 11A1 |
Inhibition |
57.0 |
% |
10.1021/jm00090a010 |
| Bos taurus |
Cytochrome P450 11A1 |
Inhibition |
57.0 |
% |
10.1021/jm00158a007 |
| Bos taurus |
Cytochrome P450 11A1 |
Inhibition |
83.0 |
% |
10.1021/jm00154a016 |
| Bos taurus |
Cytochrome P450 11A1 |
Inhibition |
85.0 |
% |
10.1021/jm00355a011 |
| Bos taurus |
Cytochrome P450 11A1 |
Inhibition |
85.0 |
% |
10.1021/jm00380a009 |
| Bos taurus |
Cytochrome P450 11A1 |
Relative potency |
1.0 |
None |
10.1021/jm00090a010 |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Candida albicans |
Candida albicans |
Inhibition |
2.63 |
% |
10.6019/CHEMBL4513141 |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-5.32 |
% |
10.6019/CHEMBL4513141 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Escherichia coli |
Escherichia coli |
Inhibition |
2.02 |
% |
10.6019/CHEMBL4513141 |
| Homo sapiens |
786-0 |
GI50 |
3419794.43 |
nM |
None |
| Homo sapiens |
A498 |
GI50 |
2312064.79 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
2877398.41 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
ACHN |
GI50 |
2488857.32 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
BT-549 |
GI50 |
1663412.65 |
nM |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
1458814.26 |
nM |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCRF-CEM |
GI50 |
665273.16 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
COLO 205 |
GI50 |
1465547.84 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 11A1 |
IC50 |
80000.0 |
nM |
10.1021/jm00106a038 |
| Homo sapiens |
Cytochrome P450 17A1 |
IC50 |
60000.0 |
nM |
10.1021/jm00108a013 |
| Homo sapiens |
Cytochrome P450 19A1 |
AC50 |
15.7 |
% |
10.1021/np8000255 |
| Homo sapiens |
Cytochrome P450 19A1 |
Activity |
7.0 |
% |
10.1021/np050513p |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
5.2 |
nM |
10.1016/j.bmcl.2010.03.113 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
250.0 |
mg kg-1 |
10.1021/jm00173a001 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
270.0 |
nM |
10.1021/jm070109i |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
270.0 |
nM |
10.1021/jm801335z |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
1700.0 |
nM |
10.1021/jm00106a038 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
1900.0 |
nM |
10.1021/jm00062a012 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
1900.0 |
nM |
10.1021/jm00108a013 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
2800.0 |
nM |
10.1016/j.bmc.2005.03.050 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
2800.0 |
nM |
10.1021/jm0306024 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
5200.0 |
nM |
10.1016/s0960-894x(02)00072-0 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
5200.0 |
nM |
10.1016/s0960-894x(02)00565-6 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
5800.0 |
nM |
10.1016/j.ejmech.2011.03.043 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
6130.0 |
nM |
10.1021/jm00154a016 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
6400.0 |
nM |
10.1016/j.ejmech.2014.11.047 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
6400.0 |
nM |
10.1021/np010288l |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
7000.0 |
nM |
10.1016/j.bmcl.2017.01.062 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
8000.0 |
nM |
10.1021/jm00392a004 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
8000.0 |
nM |
10.1021/jm00400a014 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
8300.0 |
nM |
10.1021/jm00154a016 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
9000.0 |
nM |
10.1016/j.bmcl.2017.01.062 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2009.05.003 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
10000.0 |
nM |
10.1016/j.ejmech.2022.114658 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
10000.0 |
nM |
10.1021/acs.jmedchem.5b01281 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
13000.0 |
nM |
10.1021/jm00108a013 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
14000.0 |
nM |
10.1021/jm00392a004 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
14000.0 |
nM |
10.1021/jm00400a014 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
18500.0 |
nM |
10.1016/s0960-894x(03)00182-3 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
18500.0 |
nM |
10.1016/s0960-894x(99)00328-5 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
18500.0 |
nM |
10.1021/jm00012a009 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
18500.0 |
nM |
10.1021/jm000955s |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
28500.0 |
nM |
10.1007/s00044-010-9368-4 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
28500.0 |
nM |
10.1007/s00044-012-0059-1 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
29750.0 |
nM |
10.1016/j.bmcl.2005.11.099 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
29750.0 |
nM |
10.1016/j.bmcl.2008.06.094 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
30000.0 |
nM |
10.1021/jm00106a038 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
30000.0 |
nM |
10.1021/jm00171a052 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
37000.0 |
nM |
10.1021/jm00090a010 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
37000.0 |
nM |
10.1021/jm00113a004 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
37000.0 |
nM |
10.1021/jm00158a007 |
| Homo sapiens |
Cytochrome P450 19A1 |
IC50 |
2818382931264.45 |
nM |
10.1016/j.bmc.2005.03.050 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
32.5 |
% |
10.1016/s0960-894x(99)00328-5 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
39.0 |
% |
10.1021/jm00154a025 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
43.0 |
% |
10.1021/jm00158a007 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
61.0 |
% |
10.1021/jm00154a025 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
79.0 |
% |
10.1021/jm00154a025 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
90.0 |
% |
10.1021/jm00355a011 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition |
90.0 |
% |
10.1021/jm00380a009 |
| Homo sapiens |
Cytochrome P450 19A1 |
Inhibition potency |
1.0 |
None |
10.1021/jm00108a013 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ka app |
0.13 |
uM |
10.1021/jm00380a009 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
470.0 |
nM |
10.1021/jm00106a038 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
600.0 |
nM |
10.1021/jm00173a001 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
600.0 |
nM |
10.1021/jm00380a009 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
600.0 |
nM |
10.1021/jm00392a004 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
680.0 |
nM |
10.1021/jm00154a016 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
1410.0 |
nM |
10.1016/j.bmc.2005.03.050 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
1410.0 |
nM |
10.1021/jm0306024 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
1800.0 |
nM |
10.1021/jm00392a004 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
1800.0 |
nM |
10.1021/jm00400a014 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ki |
4100.0 |
nM |
10.1016/j.ejmech.2015.09.038 |
| Homo sapiens |
Cytochrome P450 19A1 |
Km |
90.0 |
nM |
10.1016/j.bmc.2005.03.050 |
| Homo sapiens |
Cytochrome P450 19A1 |
Km |
90.0 |
nM |
10.1021/jm0306024 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ks app |
0.13 |
uM |
10.1021/jm00400a014 |
| Homo sapiens |
Cytochrome P450 19A1 |
Log IC50 |
3.45 |
nM |
10.1021/jm0306024 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ratio |
3.0 |
None |
10.1021/jm00392a004 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ratio |
15.7 |
None |
10.1021/jm0306024 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ratio |
16.0 |
None |
10.1016/j.bmc.2005.03.050 |
| Homo sapiens |
Cytochrome P450 19A1 |
Ratio IC50 |
1.0 |
None |
10.1016/j.bmcl.2005.11.099 |
| Homo sapiens |
Cytochrome P450 19A1 |
Relative potency |
1.0 |
None |
10.1016/s0960-894x(03)00182-3 |
| Homo sapiens |
Cytochrome P450 19A1 |
Relative potency |
1.0 |
None |
10.1021/jm00090a010 |
| Homo sapiens |
Cytochrome P450 19A1 |
Relative potency |
1.0 |
None |
10.1021/jm00158a007 |
| Homo sapiens |
Cytochrome P450 19A1 |
Relative Potency |
1.0 |
None |
10.1016/s0960-894x(99)00328-5 |
| Homo sapiens |
Cytochrome P450 19A1 |
RP |
1.0 |
None |
10.1021/jm00113a004 |
| Homo sapiens |
Cytochrome P450 19A1 |
RP |
1.1 |
None |
10.1021/jm00113a004 |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DLD-1 |
GI50 |
3228494.12 |
nM |
None |
| Homo sapiens |
DMS-114 |
GI50 |
1531087.46 |
nM |
None |
| Homo sapiens |
DMS-273 |
GI50 |
2558585.89 |
nM |
None |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
0.9 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
DU-145 |
GI50 |
3033891.18 |
nM |
None |
| Homo sapiens |
EKVX |
GI50 |
3881503.66 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
HCC 2998 |
GI50 |
3681289.74 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
2618183.01 |
nM |
None |
| Homo sapiens |
HCT-15 |
GI50 |
2376840.29 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
2058.8 |
nM |
None |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-21.56 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
7.95 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
HL-60 |
GI50 |
1279381.3 |
nM |
None |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
HOP-18 |
GI50 |
3118889.58 |
nM |
None |
| Homo sapiens |
HOP-62 |
GI50 |
1049542.43 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
1028016.3 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
1517050.37 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
2964831.39 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
3451437.39 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
K562 |
GI50 |
2084490.88 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KM12 |
GI50 |
2466039.34 |
nM |
None |
| Homo sapiens |
KM-20L2 |
GI50 |
3935500.75 |
nM |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
LNCaP |
IC50 |
nan |
None |
10.1021/jm801335z |
| Homo sapiens |
LOX IMVI |
GI50 |
2773320.1 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
2285598.8 |
nM |
None |
| Homo sapiens |
M19-MEL |
GI50 |
2213094.71 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
2964831.39 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
GI50 |
3006076.3 |
nM |
None |
| Homo sapiens |
MCF7 |
IC50 |
nan |
None |
10.1021/jm801335z |
| Homo sapiens |
MDA-MB-231 |
GI50 |
2612161.35 |
nM |
None |
| Homo sapiens |
MDA-MB-435 |
GI50 |
2741574.17 |
nM |
None |
| Homo sapiens |
MDA-N |
GI50 |
3250872.97 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
MOLT-4 |
GI50 |
1442115.35 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
1678804.02 |
nM |
None |
| Homo sapiens |
NCI-H226 |
GI50 |
1883649.09 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
3243396.17 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
3689775.99 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
2582260.19 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
2642408.76 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
OVCAR-3 |
GI50 |
1811340.09 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
1967886.29 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
4920395.36 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
3273406.95 |
nM |
None |
| Homo sapiens |
PC-3 |
FC |
0.979 |
None |
10.1038/nchembio790 |
| Homo sapiens |
PC-3 |
GI50 |
1166809.62 |
nM |
None |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
6012.0 |
nM |
None |
| Homo sapiens |
Peripheral myelin protein 22 |
Potency |
84921.4 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
9499.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
RPMI-8226 |
GI50 |
2488857.32 |
nM |
None |
| Homo sapiens |
RXF 393 |
GI50 |
1327394.46 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SF-268 |
GI50 |
2857590.54 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
1883649.09 |
nM |
None |
| Homo sapiens |
SF-539 |
GI50 |
3243396.17 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-MEL-2 |
GI50 |
3507518.74 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
3605786.43 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
2089296.13 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
1191242.01 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
3396252.73 |
nM |
None |
| Homo sapiens |
SN12K1 |
GI50 |
1694337.8 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
3349654.39 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
1905460.72 |
nM |
None |
| Homo sapiens |
SNB-78 |
GI50 |
2172701.18 |
nM |
None |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
52.33 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
77.0 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
SR |
GI50 |
3819442.71 |
nM |
None |
| Homo sapiens |
SW-620 |
GI50 |
3515604.41 |
nM |
None |
| Homo sapiens |
T47D |
GI50 |
2074913.52 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
18500.0 |
nM |
10.1021/jm991180u |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
TK-10 |
GI50 |
2172701.18 |
nM |
None |
| Homo sapiens |
Transcriptional regulator ERG |
Potency |
891.3 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
U-251 |
GI50 |
2051162.18 |
nM |
None |
| Homo sapiens |
UACC-257 |
GI50 |
2648500.14 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
1815515.66 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
1927524.91 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
XF498 |
GI50 |
1548816.62 |
nM |
None |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
3.02 |
% |
10.6019/CHEMBL4513141 |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania major |
Leishmania major |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Monoamine oxidase B |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
P388 |
GI50 |
2393315.76 |
nM |
None |
| Mus musculus |
P388/ADR |
GI50 |
1606941.25 |
nM |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Pneumocystis carinii |
Pneumocystis carinii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
14.25 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cytochrome P450 11B2 |
IC50 |
50000.0 |
nM |
10.1021/jm00012a009 |
| Rattus norvegicus |
Cytochrome P450 11B2 |
IC50 |
80000.0 |
nM |
10.1021/jm00012a009 |
| Rattus norvegicus |
Cytochrome P450 11B2 |
IC50 |
110000.0 |
nM |
10.1021/jm00108a013 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
EC50 |
260.0 |
nM |
10.1021/jm00391a016 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
ED |
2.3 |
mg kg-1 |
10.1021/jm00108a013 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
ED50 |
30.0 |
mg.kg-1 |
10.1021/jm00106a038 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Effect |
97.0 |
None |
10.1021/jm00035a007 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
IC50 |
6200.0 |
nM |
10.1021/jm00012a009 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
IC50 |
34000.0 |
nM |
10.1021/jm00113a004 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Inhibition |
37.0 |
% |
10.1021/jm00012a009 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Inhibition |
41.33 |
% |
10.1007/s00044-010-9442-y |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Inhibition |
53.0 |
% |
10.1021/jm00012a009 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Inhibition |
67.0 |
% |
10.1021/jm00383a017 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Inhibition |
73.0 |
% |
10.1021/jm00012a009 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Inhibition |
73.0 |
% |
10.1021/jm00035a007 |
| Rattus norvegicus |
Cytochrome P450 19A1 |
Inhibition |
80.0 |
% |
10.1021/jm00383a017 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
37300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
40700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALB |
43300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
251.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
367.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALP |
463.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
54.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
56.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
ALT |
78.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
87.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
91.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
AST |
137.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASO |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BASOLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
1.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BILI |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
120.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
166.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
BUN |
170.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Change of tumor area |
4.0 |
% |
10.1021/jm00035a007 |
| Rattus norvegicus |
Rattus norvegicus |
Change of tumor area |
17.0 |
% |
10.1021/jm00035a007 |
| Rattus norvegicus |
Rattus norvegicus |
Change of tumor area |
23.0 |
% |
10.1021/jm00035a007 |
| Rattus norvegicus |
Rattus norvegicus |
Change of tumor area |
54.0 |
% |
10.1021/jm00035a007 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
100.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHLORIDE |
102.0 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
670.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
693.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CHOL |
1036.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
282.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
357.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CK |
398.0 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
26000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27000000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CO2 |
27330000.0 |
nM |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.4 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
1.6 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
CREAT |
2.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOS |
0.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
EOSLE |
0.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1200.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1556.7 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
GLUC |
1600.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
34.23 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
35.6 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HCT |
37.93 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
134700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
141000.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
HGB |
151300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
12.0 |
% |
10.1021/jm00012a009 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
40.0 |
% |
10.1021/jm00012a009 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
67.0 |
% |
10.1021/jm00113a004 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
67.0 |
% |
10.1021/jm00158a007 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
68.0 |
% |
10.1021/jm00113a004 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
202.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
241.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LDH |
347.67 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
9.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
10.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LIPASE |
12.33 |
U.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
11710.67 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
12308.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYM |
14655.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
80.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
84.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
LYMLE |
90.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
23.57 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
24.23 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCH |
25.1 |
pg |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
393300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
396700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCHC |
398700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
59.1 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
61.17 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MCV |
63.77 |
fL |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
54.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
135.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONO |
267.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
0.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
MONOLE |
1.67 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
9.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
14.33 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTLE |
18.0 |
% |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1457.33 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
1890.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
NEUTSG |
2622.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
New tumors |
4.0 |
None |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
New tumors |
5.0 |
None |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
No. of tumors |
7.0 |
None |
10.1021/jm00035a007 |
| Rattus norvegicus |
Rattus norvegicus |
No. of tumors |
18.0 |
None |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
No. of tumors |
24.0 |
None |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
No. of tumors |
35.0 |
None |
10.1021/jm00035a007 |
| Rattus norvegicus |
Rattus norvegicus |
Of tumors |
6.0 |
% |
10.1021/jm00035a007 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
118.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
120.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PHOS |
130.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Plasma-E2 concentration |
164.0 |
pg ml-1 |
10.1021/jm00113a004 |
| Rattus norvegicus |
Rattus norvegicus |
Plasma-E2 concentration |
272.0 |
pg ml-1 |
10.1021/jm00113a004 |
| Rattus norvegicus |
Rattus norvegicus |
Plasma-E2 concentration |
500.0 |
pg ml-1 |
10.1021/jm00113a004 |
| Rattus norvegicus |
Rattus norvegicus |
Plasma-E2 concentration |
843.0 |
pg ml-1 |
10.1021/jm00113a004 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1044000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1180670.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PLAT |
1364330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
5.62 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.27 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
POTASSIUM |
6.52 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
52300.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
56700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
PROT |
58700.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5370000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
5820000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBC |
6410000.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
RBCNUC |
0.0 |
/100WBC |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Response |
4.1 |
% |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
Response |
4.25 |
% |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
Response |
11.2 |
% |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
Response |
22.2 |
% |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
Response |
66.6 |
% |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
Response |
91.6 |
% |
10.1021/jm00108a013 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
142.47 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
143.27 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
SODIUM |
144.37 |
mEq.L-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
Tissue Severity Score |
nan |
None |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
17.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.0 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
URATE |
18.3 |
ug.mL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14330.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
14600.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Rattus norvegicus |
WBC |
16170.0 |
cells.uL-1 |
10.6019/CHEMBL3885881 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
188.9 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
42284.1 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.05748 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
-4.21 |
% |
10.6019/CHEMBL4513141 |
| Toxoplasma gondii |
Toxoplasma gondii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
ADMET |
Biotransformation |
nan |
None |
10.1038/s41586-019-1291-3 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Alkaline Phosphatase Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Active |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Marginal |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Composite Activity - Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
GGT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LDH Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
LDH Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGOT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Activity Score |
nan |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Index Value |
0.0 |
None |
10.2174/1570163043334794 |
| None |
Hepatotoxicity |
SGPT Increase - Number of Reports |
4.0 |
None |
10.2174/1570163043334794 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
67.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
50000.0 |
nM |
10.1021/jm00108a013 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1021/jm801335z |
| None |
NON-PROTEIN TARGET |
Potency |
0.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
0.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
1.1 |
nM |
None |
| None |
No relevant target |
LogD7.4 |
0.6 |
None |
10.6019/CHEMBL3301361 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
7.079 |
uM |
None |
| None |
Unchecked |
Ac50 |
10.0 |
uM |
None |
| None |
Unchecked |
AC50 |
7079.5 |
nM |
None |
| None |
Unchecked |
AC50 |
10000.0 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
82.9 |
nM |
10.1021/jm800012w |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
20.0 |
nM |
None |
| None |
Unchecked |
Potency |
112.2 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |